Prosigna Kits
Breast cancer prognostic tests are genomic tests which are used to determine a woman's risk of hormone receptor breast cancer recurrence as well as how likely she is to benefit from chemotherapy after breast cancer surgery and/or extended endocrine treatm
Buyer
Royal Marsden NHS Foundation Trust
Value
£204,000
Published
13 Jan 2022
Closes
19 Dec 2021
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Other
Category
Goods
Contract starts
20 Dec 2021
Contract ends
19 Dec 2023
CPV classifications
33141620
Medical kits
Lots
Lot default Prosigna Kits
£204,000
Breast cancer prognostic tests are genomic tests which are used to determine a woman's risk of hormone receptor breast cancer recurrence as well as how likely she is to benefit from chemotherapy after breast cancer surgery and/or extended endocrine treatm
Delivery: British Oversea Territories, Channel Islands, Europe, Isle of Man, Rest of the World, United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
13 Jan 2022
Awarded contract notice on Contracts Finder
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.